How It Works
Watch Maverick™ Technology In Action
31 Patent Issued and 17 Pending
Our proprietary Marverick™ Diagnostic System (MDS) has 31 patents issued and 17 patents pending worldwide.
FDA Clearance and EUA Authorization
The MaverickTM Diagnostic System (MDS) received FDA clearance for RNP (ribonuceloprotein) assay in October 2019.
In addition, the MaverickTM Diagnostic System (MDS) received Emergency Use Authorization (EUA) by the FDA for SARS-CoV-2 Multi-Antigen Serology Panel in October 2020
Improving overall patient care
In order to improve overall patient care with rapid laboratory diagnostics, Genalyte became a clinical diagnostic provider receiving CLIA certification and CAP accreditation in 2017